Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Details)

v3.20.2
Note 3 - Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Accrued chemistry manufacturing and control costs $ 1,086 $ 49
Accrued clinical activities 311 93
Accrued payroll and bonuses 247 436
Operating lease liability - current 114 103
Related party payable 99 99
Accrued license fees and sponsored research agreements 95 201
Accrued legal, regulatory, and professional 87 272
Accrued other 56 164
Total accrued expenses and other current liabilities $ 2,095 $ 1,417